Found 51 results in Expert Content

Summary: This webinar explores the world of pediatric dosage forms and how ODTs are emerging as a specialized drug delivery system for children.

Summary: Read this article to learn how orally dissolving tablets (ODTs) help address dysphagia concerns and enhance compliance and adherence.

Summary: Whether you are looking for accelerated development for your novel therapy, to transform your concepts into differentiated products to grow your brand, or lifecycle management to extend market share and maximize product value, Catalent can be your...

Gain valuable insights into the benefits of Zydis fast-dissolve technology and how it can optimize your product for commercial success.

Summary: Zydis ODT offers rapid disintegration, a good mouthfeel and pleasant taste which plays a role in improving patient engagement in their treatment programs and offers an easy-to-take alternative to conventional oral tablets to help meet the needs of specific patient populations such as pediatric, geriatric and dysphagic patients.

Summary: Zydis® orally disintegrating tablet (ODT) technology creates a unique, freeze-dried oral solid dosage form that disperses almost instantly in the mouth, without water. With more than 35 products launched in 60+ countries, Zydis is the world’s fastest and best-in-class ODT.

In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.

Summary: In this webinar, participants will both hear a panel of industry experts discuss practical challenges in oral drug development and gain valuable insights into current approaches to overcoming challenges in developing oral dosage forms that are more patient-friendly.

Summary: This article explores the needs of different patient groups, identifies frequent issues leading to non-compliance, looks at the role of orally disintegrating tablets (ODTs) in helping improve patient compliance, and provides examples of improving the delivery profile of the drug.

Summary: In this executive summary, we describe the benefits of controlled release, how to determine whether a drug is suitable for controlled release and more.